Finally, to conclusively measure mitochondrial metabolic capacity in patient-derived GBM cells, we performed Oroboros respirometry to quantify the oxygen consumption rate (OCR) of CD133/PROM1LOW and CD133/PROM1HIGH patient-derived GBM cells. The gene discussed is PROM1; the disease is glioblastoma.